PINK1 anticorps (E417G)
Aperçu rapide pour PINK1 anticorps (E417G) (ABIN2764094)
Antigène
Voir toutes PINK1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- E417G
-
Réactivité croisée
- Humain
-
Attributs du produit
- PTEN-induced putative kinase protein 1,Protects against mitochondrial dysfunction during cellular stress, potentially by phosphorylating mitochondrial proteins. Involved in the clearance of damaged mitochondria via selective autophagy (mitophagy). It is necessary for PARK2 recruitment to dysfunctional mitochondria to initiate their degradation. Defects in PINK1 are the cause of Parkinson disease type 6 (PARK6). A neurodegenerative disorder characterized by parkinsonian signs such as rigidity, resting tremor and bradykinesia. A subset of patients manifest additional symptoms including hyperreflexia, autonomic instability, dementia and psychiatric disturbances. Symptoms show diurnal fluctuation and can improve after sleep.
-
Purification
- Antigen Immunoaffiinity Purification
-
Immunogène
- Synthetic peptide derived from a mutant form of the human PINK1 protein
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal concentration should be evaluated by serial dilutions.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- Provided as solution in phosphate buffered saline with 0.08 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Product should be stored at -20°C. Aliquot to avoid freeze/thaw cycles
-
-
-